Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Virginia?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Virginia resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Virginia-licensed prescriber, including by telemedicine under the bona fide practitioner-patient relationship rules in Virginia Code section 54.1-3303, and can obtain a compounded peptide when it is dispensed by a pharmacy permitted or registered by the Virginia Board of Pharmacy and meets both federal 503A rules and Virginia's own compounding statute, section 54.1-3410.2. Nonresident pharmacies must register under section 54.1-3434.1, name a Virginia-licensed pharmacist in charge, and submit a recent home-state inspection showing USP compliance.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Adds state-specific limits to the 503A framework
Telehealth prescribing
Allowed, asynchronous allowed; a questionnaire alone is not enough
Compounded GLP-1
Limited

Can a Virginia resident get peptides by telehealth?

Virginia Code section 54.1-3303 requires a bona fide practitioner-patient relationship for every prescription: the practitioner must obtain a medical and drug history, explain the benefits and risks of the drug, perform an appropriate examination, and initiate follow-up care as needed. The statute lets a prescriber establish that relationship by an examination through face-to-face interactive, two-way, real-time communication or through store-and-forward technologies when listed conditions are met, including that the prescriber reviews the patient's history and updates it at the time of prescribing, makes a diagnosis then, meets the in-person standard of care, holds an active Virginia license, and that the standard of care does not require an in-person examination. If the patient is enrolled in a health plan, the prescriber must also be credentialed by that plan. Virginia classifies prescription-only drugs that are not otherwise scheduled as Schedule VI, so GLP-1 medicines and prescription peptides fall under these Schedule II through VI provisions; the separate requirement to keep a Virginia practice location or referral arrangement applies only to Schedules II through V. The Board of Medicine's telemedicine guidance (document 85-12, effective August 19, 2021) adds that an online questionnaire, email, fax, or audio-only call is not a telemedicine service and that a new relationship must meet the section 54.1-3303 requirements. The Board's guidance also states that treatment, including issuing a prescription, based solely on an online questionnaire does not constitute an acceptable standard of care. This record classifies asynchronous prescribing as allowed because the statute expressly names store-and-forward technologies as a way to perform the examination, subject to the listed conditions and the standard of care, but a questionnaire alone is not enough. [2] [3] [4] [7]

How does the Virginia pharmacy board treat compounding?

Compounding regulator for Virginia
BoardVirginia Board of Pharmacy (Virginia Department of Health Professions)
Eligible substancesAdds state-specific limits to the 503A framework

The Virginia Board of Pharmacy regulates pharmacies under the Drug Control Act (Virginia Code title 54.1, chapter 34) and regulations at 18VAC110-20; regulation 18VAC110-20-321 requires compounding to follow USP-NF compounding standards and section 54.1-3410.2. That statute allows compounding for specific patient prescriptions or in anticipation of prescriptions based on an observed prescribing pattern, and subsection F sets Virginia's own two-part test for bulk drug substances: the substance must meet an applicable USP or NF monograph (if one exists) and the USP compounding chapter, or be a component of an FDA approved drug, or be otherwise approved by FDA, or be made by an FDA-registered establishment; and it must come from a licensed or registered wholesale distributor or a supplier approved by the Board and FDA. Neither section 54.1-3410.2 nor 18VAC110-20-321 mentions the FDA 503A bulks list, so the state test does not turn on that list; federal 503A limits, including the bulks list, still apply to every Virginia compounder, and the state sourcing and USP requirements add to them. Section 54.1-3434.1 requires nonresident pharmacies to register, designate a pharmacist in charge licensed in Virginia, and submit a home-state inspection (within six months for a new registration, two years for renewal) showing USP compliance for compounding. [1] [5] [6] [8] [9] [10]

Can you get compounded GLP-1s in Virginia?

Regulatory: Compounded GLP-1 limited

Out-of-state telehealth programs must dispense through a pharmacy registered under section 54.1-3434.1 with a Virginia-licensed pharmacist in charge. [5] [6] [13]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Virginia?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Virginia

What you'll actually find in Virginia, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [17] [18] [19]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [20]

What Virginia has done

PeptideAgent has not found a board or legislative action on peptides in Virginia.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [22] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [23] [24] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Virginia. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough. [2] [3] [4] [7] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Virginia Board of Pharmacy (Virginia Department of Health Professions); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [21]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [20]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [25] [26]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [21] [27] [28]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [19] [28] [29]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [20] [30] [31] [32] [33] [34]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [20]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [21]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [19]
  • Pharmacy: Is this made for me on a prescription written in my name? [29]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [19] [28]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [19]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Virginia?

The Virginia Drug Control Act restricts the sale and dispensing of Schedule VI (prescription-only) drugs to licensed practitioners and permitted or registered pharmacies, so injectable peptides sold to Virginia consumers as "research use only" are outside the licensed supply chain. [1] [7] [14]

Peptide-specific notes for Virginia

Peptide-specific notes for Virginia
PeptideNote
SemaglutideA Schedule VI drug in Virginia, available branded by prescription, including after a real-time or store-and-forward telemedicine examination under section 54.1-3303. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [4] [13]
BPC-157Not FDA approved and not on the 503A bulks list; its nomination was withdrawn in April 2026. On October 28, 2026 HHS released a draft enforcement discretion policy covering single-ingredient BPC-157 compounded by a state-licensed pharmacy by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's tested substance, with serious adverse events reported to FDA. It is not an FDA approval, is not binding, and does not cover blends such as Wolverine. FDA's drug center recommended against listing; the advisory committee voted in favor (HHS policy, Appendix B). Virginia's own bulk substance criteria in section 54.1-3410.2 add a second hurdle. [5] [11] [12] [15] [16]

Frequently asked questions

Can I get a GLP-1 prescription in Virginia through telemedicine?

Yes. Virginia Code section 54.1-3303 lets a Virginia-licensed prescriber establish a bona fide practitioner-patient relationship through real-time two-way communication or store-and-forward technology, as long as the conditions listed in the statute are met and the standard of care does not require an in-person exam. The prescriber must still take a history, explain risks and benefits, make a diagnosis, and arrange follow-up. Board of Medicine guidance says a prescription based solely on an online questionnaire is not an acceptable standard of care. [3] [4]

Why does Virginia call GLP-1 drugs Schedule VI?

Virginia's Drug Control Act places every prescription-only drug that is not in Schedules I to V into Schedule VI. It does not mean the drug is a controlled substance in the federal sense; it simply means a prescription is required, and the telemedicine rules in section 54.1-3303 apply. [4] [7]

What does an out-of-state pharmacy need to ship compounded peptides to Virginia?

Registration as a nonresident pharmacy under section 54.1-3434.1, a pharmacist in charge licensed in Virginia, and a current home-state inspection report showing compliance with USP-NF standards for sterile and non-sterile compounding. The Department of Health Professions license lookup shows registration status. [1] [6]

Is compounded semaglutide or tirzepatide still available in Virginia?

Only in limited, patient specific cases. The FDA shortage allowances ended in 2025, and Virginia pharmacies must also meet the state's compounding statute, section 54.1-3410.2, so a GLP-1 can be compounded only for a documented need the approved product cannot meet. [5] [13]

Does Virginia have its own compounding law?

Yes. Section 54.1-3410.2 governs compounding in Virginia: it limits compounding to patient prescriptions or observed prescribing patterns, requires USP-NF compliance, sets bulk substance sourcing criteria, and regulates compounded products supplied for office administration. Federal 503A limits apply on top of it. [5] [10]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Virginia Board of Pharmacy (Department of Health Professions)
  2. [2]Virginia Board of Medicine (Department of Health Professions)
  3. [3]Virginia Board of Medicine guidance document 85-12: Telemedicine (Virginia Regulatory Town Hall)
  4. [4]Virginia Code section 54.1-3303, Prescriptions to be issued and drugs to be dispensed for medical or therapeutic purposes only
  5. [5]Virginia Code section 54.1-3410.2, Compounding
  6. [6]Virginia Code section 54.1-3434.1, Nonresident pharmacies to register with Board
  7. [7]Virginia Code section 54.1-3455, Schedule VI
  8. [8]18VAC110-20, Regulations governing the practice of pharmacy
  9. [9]18VAC110-20-321, Compounding
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Virginia?. https://peptideagent.ai/legal/virginia
HTML link
<a href="https://peptideagent.ai/legal/virginia">Are peptides legal in Virginia?</a>, PeptideAgent, updated October 28, 2026.